The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species
Abstract
Reactive oxygen species (ROS) plays a key role in therapeutic effects as well as side effects of platinum drugs. Cisplatin mediates activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX), which triggers oxygen (O 2 ) to superoxide radical (O 2 • – ) and its downstream H 2 O 2 . Through the Fenton’s reaction, H 2 O 2 could be catalyzed by Fe 2+ /Fe 3+ to the toxic hydroxyl radicals ( • OH), which cause oxidative damages to lipids, proteins, and DNA. By taking the full advantage of Fenton’s chemistry, we herein demonstrated tumor site-specific conversion of ROS generation induced by released cisplatin and Fe 2+ /Fe 3+ from iron-oxide nanocarriers with cisplatin(IV) prodrugs for enhanced anticancer activity but minimized systemic toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Photodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
Sharma, P., Jha, A. B., Dubey, R. S., & Pessarakli, M. (2012) · Journal of Botany · doi:10.1155/2012/217037 · Cited by 5,473
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Reactive oxygen species, cellular redox systems, and apoptosis
Circu, M. L., & Aw, T. Y. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.12.022 · Cited by 3,340
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
Ethirajan, M., Chen, Y., Joshi, P., & Pandey, R. K. (2011) · Chem. Soc. Rev. · doi:10.1039/b915149b · Cited by 2,034
Mechanisms of Cisplatin Nephrotoxicity
Miller, R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010) · Toxins · doi:10.3390/toxins2112490 · Cited by 1,622
Molecular mechanisms of resistance and toxicity associated with platinating agents
Rabik, C. A., & Dolan, M. E. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.09.006 · Cited by 1,564
Identification of ROS Using Oxidized DCFDA and Flow-Cytometry
Eruslanov, E., & Kusmartsev, S. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-411-1_4 · Cited by 1,321
Zhang, C., Bu, W., Ni, D., Zhang, S., Li, Q., Yao, Z., Zhang, J., Yao, H., Wang, Z., & Shi, J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510031 · Cited by 1,269
Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
Steinherz, L. J. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470120074036 · Cited by 989
Antitumour metal compounds: more than theme and variations
Jakupec, M. A., Galanski, M. S., Arion, V. B., Hartinger, C. G., & Keppler, B. K. (2008) · Dalton Transactions · doi:10.1039/b712656p · Cited by 850
Marullo, R., Werner, E., Degtyareva, N., Moore, B., Altavilla, G., Ramalingam, S. S., & Doetsch, P. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081162 · Cited by 777
Šimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 769
The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and Pitfalls
Vercauteren, D., Vandenbroucke, R. E., Jones, A. T., Rejman, J., Demeester, J., De Smedt, S. C., Sanders, N. N., & Braeckmans, K. (2010) · Molecular Therapy · doi:10.1038/mt.2009.281 · Cited by 689
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Wilson, J. J., & Lippard, S. J. (2014) · Chemical Reviews · doi:10.1021/cr4004314 · Cited by 630
Feazell, R. P., Nakayama-Ratchford, N., Dai, H., & Lippard, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073231f · Cited by 616
Meyers, C. A., Smith, J. A., Bezjak, A., Mehta, M. P., Liebmann, J., Illidge, T., Kunkler, I., Caudrelier, J.-M., Eisenberg, P. D., Meerwaldt, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.128 · Cited by 585
Monodisperse Magnetic Nanoparticles for Theranostic Applications
Ho, D., Sun, X., & Sun, S. (2011) · Accounts of Chemical Research · doi:10.1021/ar200090c · Cited by 504
Artemisinins: Pharmacological actions beyond anti-malarial
Ho, W. E., Peh, H. Y., Chan, T. K., & Wong, W. S. F. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.001 · Cited by 481
Light‐Activated Hypoxia‐Responsive Nanocarriers for Enhanced Anticancer Therapy
Qian, C., Yu, J., Chen, Y., Hu, Q., Xiao, X., Sun, W., Wang, C., Feng, P., Shen, Q., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201505869 · Cited by 466
Self-citationAi, X., Ho, C. J. H., Aw, J., Attia, A. B. E., Mu, J., Wang, Y., Wang, X., Wang, Y., Liu, X., Chen, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10432 · Cited by 433
Nanocarriers for delivery of platinum anticancer drugs
Oberoi, H. S., Nukolova, N. V., Kabanov, A. V., & Bronich, T. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.014 · Cited by 396
Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies
Rybak, L. P., Mukherjea, D., Jajoo, S., & Ramkumar, V. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.219.177 · Cited by 372
ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors
Halasi, M., Wang, M., Chavan, T. S., Gaponenko, V., Hay, N., & Gartel, A. L. (2013) · Biochemical Journal · doi:10.1042/bj20130282 · Cited by 366
Platinum Drug Distribution in Cancer Cells and Tumors
Klein, A. V., & Hambley, T. W. (2009) · Chemical Reviews · doi:10.1021/cr9001066 · Cited by 351
Xu, X., Xie, K., Zhang, X.-Q., Pridgen, E. M., Park, G. Y., Cui, D. S., Shi, J., Wu, J., Kantoff, P. W., Lippard, S. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303958110 · Cited by 340
Self-citationShen, J., Zhao, L., & Han, G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.05.007 · Cited by 309
Min, Y., Li, J., Liu, F., Yeow, E. K. L., & Xing, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308834 · Cited by 309
Ultralow-Power Near Infrared Lamp Light Operable Targeted Organic Nanoparticle Photodynamic Therapy
Huang, L., Li, Z., Zhao, Y., Zhang, Y., Wu, S., Zhao, J., & Han, G. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b05390 · Cited by 301
Punjabi, A., Wu, X., Tokatli-Apollon, A., El-Rifai, M., Lee, H., Zhang, Y., Wang, C., Liu, Z., Chan, E. M., Duan, C., et al. (2014) · ACS Nano · doi:10.1021/nn505051d · Cited by 284
Roles of NADPH Oxidases in Cisplatin-Induced Reactive Oxygen Species Generation and Ototoxicity
Kim, H.-J., Lee, J.-H., Kim, S.-J., Oh, G. S., Moon, H.-D., Kwon, K.-B., Park, C., Park, B. H., Lee, H.-K., Chung, S.-Y., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6054-09.2010 · Cited by 280
Functionalization of Platinum Complexes for Biomedical Applications
Wang, X., Wang, X., & Guo, Z. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00203 · Cited by 268
Reactive oxygen species-related activities of nano-iron metal and nano-iron oxides
Wu, H., Yin, J.-J., Wamer, W. G., Zeng, M., & Lo, Y. M. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.01.007 · Cited by 257
Urrutia, P. J., Mena, N. P., & Núñez, M. T. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00038 · Cited by 243
Artemisinins: mechanisms of action and potential for resistance
KRISHNA, S., UHLEMANN, A., & HAYNES, R. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.07.001 · Cited by 243
Targeted delivery of platinum-based anticancer complexes
Butler, J. S., & Sadler, P. J. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.01.004 · Cited by 237
Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
Min, Y., Mao, C., Chen, S., Ma, G., Wang, J., & Liu, Y. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201562 · Cited by 222
Self-citationIron and Reactive Oxygen Species: Friends or Foes of Cancer Cells?
Bystrom, L. M., Guzman, M. L., & Rivella, S. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5014 · Cited by 212
Xiao, H., Song, H., Yang, Q., Cai, H., Qi, R., Yan, L., Liu, S., Zheng, Y., Huang, Y., Liu, T., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.049 · Cited by 200
Self-citationBiodegradable polymer − cisplatin(IV) conjugate as a pro-drug of cisplatin(II)
Xiao, H., Qi, R., Liu, S., Hu, X., Duan, T., Zheng, Y., Huang, Y., & Jing, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.072 · Cited by 187
Self-citationCombating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
Min, Y., Mao, C., Chen, S., Ma, G., Wang, J., & Liu, Y. (2012) · Angewandte Chemie · doi:10.1002/ange.201201562 · Cited by 181
Self-citationInorganic nanocarriers for platinum drug delivery
Ma, P., Xiao, H., Li, C., Dai, Y., Cheng, Z., Hou, Z., & Lin, J. (2015) · Materials Today · doi:10.1016/j.mattod.2015.05.017 · Cited by 151
Self-citationMa, P., Xiao, H., Li, X., Li, C., Dai, Y., Cheng, Z., Jing, X., & Lin, J. (2013) · Advanced Materials · doi:10.1002/adma.201301713 · Cited by 140
Self-citationZhang, W., Hao, W., & Frei, B. B. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009229 · Cited by 125
Itoh, T., Terazawa, R., Kojima, K., Nakane, K., Deguchi, T., Andô, M., Tsukamasa, Y., Ito, M., & Nozawa, Y. (2011) · Free Radical Research · doi:10.3109/10715762.2011.591391 · Cited by 124
Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells
Kalayda, G. V., Wagner, C. H., & Jaehde, U. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.07.010 · Cited by 90
Evens, A. M., Lecane, P. S., Magda, D. J., Prachand, S., Singhal, S., Nelson, J. S., Miller, R. A., Gartenhaus, R. B., & Gordon, L. I. (2004) · Blood · doi:10.1182/blood-2004-03-0964 · Cited by 85
An introduction to the metabolic determinants of anthracycline cardiotoxicity
Menna, P., Recalcati, S., Cairo, G., & Minotti, G. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0011-7 · Cited by 83
Oh the irony: Iron as a cancer cause or cure?
Foy, S. P., & Labhasetwar, V. D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.047 · Cited by 54
Kim, S.-J., Hur, J. H., Park, C., Kim, H., Oh, G., Lee, J. N., Yoo, S.-J., Choe, S., So, H., LIM, D. J., et al. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.112 · Cited by 52
Magnetic Resonance-Guided Drug Delivery
Mikhail, A. S., Partanen, A., Yarmolenko, P., Venkatesan, A. M., & Wood, B. J. (2015) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2015.05.012 · Cited by 20
DNA strand breakage by bivalent metal ions and ionizing radiation
Ayene, I. S., Koch, C. J., & Krisch, R. E. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000601146956 · Cited by 17
Cited by
Targeting Ferroptosis to Iron Out Cancer
Hassannia, B., Vandenabeele, P., & Vanden Berghe, T. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.002 · Cited by 2,478
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
Recent Progress in Ferroptosis Inducers for Cancer Therapy
Liang, C., Zhang, X., Yang, M., & Dong, X. (2019) · Advanced Materials · doi:10.1002/adma.201904197 · Cited by 1,569
Self-citation
Metadata
- Authors
- Ma, P., Xiao, H., Yu, C., Liu, J., Cheng, Z., Song, H., Zhang, X., Li, C., Wang, J., Gu, Z., & Lin, J.
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-01-31
- Volume
- 17
- Issue
- 2
- Pages
- 928-937
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W2583207915
- Cited by
- 649
- References
- 55
- FWCI
- 22.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.